These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18973843)

  • 1. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.
    Poynard T; Muntenau M; Morra R; Ngo Y; Imbert-Bismut F; Thabut D; Messous D; Massard J; Lebray P; Moussalli J; Benhamou Y; Ratziu V
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):8-21. PubMed ID: 18973843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
    Maor Y; Calès P; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2007 Nov; 13(6):722-9. PubMed ID: 17973848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
    Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
    J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
    Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
    Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
    Munteanu M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):173-4. PubMed ID: 17592566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-invasive evaluation of liver fibrosis in hepatitis C].
    de Lédinghen V; Poynard T; Wartelle C; Rosenthal E
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S90-5. PubMed ID: 18675186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?
    Mardini H; Record C
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):441-7. PubMed ID: 16259794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to measure liver fibrosis in viral hepatitis?].
    Pariente A
    Rev Prat; 2005 Mar; 55(6):646-9. PubMed ID: 15913116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.